B

BL PharmTech Corp
KOSDAQ:065170

Watchlist Manager
BL PharmTech Corp
KOSDAQ:065170
Watchlist
Price: 3 145 KRW 2.11% Market Closed
Market Cap: ₩83.9B

BL PharmTech Corp
Goodwill

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

BL PharmTech Corp
Goodwill Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Goodwill CAGR 3Y CAGR 5Y CAGR 10Y
B
BL PharmTech Corp
KOSDAQ:065170
Goodwill
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
AmorePacific Corp
KRX:090430
Goodwill
₩789.4B
CAGR 3-Years
321%
CAGR 5-Years
114%
CAGR 10-Years
38%
Amorepacific Group
KRX:002790
Goodwill
₩1.3T
CAGR 3-Years
36%
CAGR 5-Years
20%
CAGR 10-Years
9%
Cosmax Inc
KRX:192820
Goodwill
₩39.3B
CAGR 3-Years
0%
CAGR 5-Years
-16%
CAGR 10-Years
51%
LG H&H Co Ltd
KRX:051900
Goodwill
₩729.9B
CAGR 3-Years
-8%
CAGR 5-Years
-7%
CAGR 10-Years
0%
Kolmar Korea Co Ltd
KRX:161890
Goodwill
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

BL PharmTech Corp
Glance View

Market Cap
83.9B KRW
Industry
Consumer products

BL Pharmtech Corp. engages in health food industry. The company is headquartered in Yongin, Gyeonggi-Do. The company went IPO on 2002-11-19. The firm operates its business through four segments. The Health Functional Food Business segment is engaged in the manufacture and sale of products such as red ginsengs, diet foods and vitamins. The Cosmetics Business segment is engaged in the manufacture and sale of anti-aging skincare products and, among others. The Diagnostic and Medical Business segment is engaged in the manufacture and sale of diagnostic kits and other products. The Other segment is engaged in the distribution of health foods and other products.

Intrinsic Value
411.99 KRW
Overvaluation 87%
Intrinsic Value
Price
B

See Also

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett